Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Select Medical Holdings Corp (NYSE: SEM) is making waves in the healthcare sector, currently trading at $11.97 with a market capitalization of $1.48 billion. With its robust portfolio in critical..
Bausch Health Companies Inc. (NYSE: BHC), a diversified healthcare giant with a robust portfolio in specialty pharmaceuticals and medical devices, is capturing investor attention with a notable potential upside of..
Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, operates across the United States, focusing on senior living communities. With its diversified portfolio, including Independent Living,..
CG Oncology, Inc. (NASDAQ: CGON) is capturing the attention of the investment community with a striking potential upside of 117.71%, as highlighted by the latest analyst ratings. Specializing in innovative..
Warby Parker Inc. (NYSE: WRBY) has carved out a unique niche in the healthcare sector, specifically within the medical instruments and supplies industry, by revolutionizing how consumers purchase eyewear. As..
For investors with an eye on the healthcare industry, Schrodinger, Inc. (SDGR) presents itself as a compelling opportunity worth exploring. This New York-based company, operating in the health information services..
As investors navigate the tumultuous seas of the stock market, opportunities in the biotech sector often present themselves as high-risk, high-reward ventures. Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is drawing attention..
LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, is attracting significant investor attention with a potential upside of 43.12%. This intriguing figure, coupled with a strong buy..
For investors keen on exploring opportunities within the healthcare sector, Concentra Group Holdings Parent (NYSE: CON) presents a compelling case. As a leader in occupational health services in the United..
For investors with an eye on the biotechnology sector, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presents a compelling opportunity. The company, with a market cap of $2.61 billion, operates within the..
Zai Lab Limited (NASDAQ: ZLAB), a dynamic player in the biotechnology sector, offers a promising yet complex investment opportunity. Headquartered in Pudong, China, Zai Lab is actively engaged in the..
Merus N.V. (NASDAQ: MRUS), a Netherlands-based clinical-stage biotechnology company, is capturing investor attention with its promising pipeline of bispecific antibody therapeutics and a robust potential upside of 34.47%. Specializing in..
Viking Therapeutics, Inc. (NASDAQ: VKTX) has garnered significant attention in the biotechnology sector with its innovative approach to treating metabolic and endocrine disorders. Headquartered in San Diego, California, Viking Therapeutics..
Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, stands at the forefront of innovation in the healthcare sector, focusing primarily on oncology and immunology. With a market capitalization of $2.2..
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out in the healthcare sector, specifically in the biotechnology industry, with a focus on addressing rare endocrine diseases and endocrine-related tumors. Headquartered in San..
Privia Health Group, Inc. (NASDAQ: PRVA), a leader in the healthcare sector, is rapidly gaining attention from investors. With its innovative approach to physician enablement and a remarkable potential upside..
Addus HomeCare Corporation (NASDAQ: ADUS) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.97 billion, Addus HomeCare..
Envista Holdings Corporation (NYSE: NVST) offers a compelling investment case within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of $3.47 billion, this..
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is carving out a significant niche in the biotechnology sector, focusing on developing groundbreaking treatments for intractable diseases. With a market capitalization of $2.27 billion,..
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its innovative approach to treating rare and neurological diseases. Based in Plymouth Meeting, Pennsylvania, Harmony Biosciences..
